Week 196 Review - As flat as it gets

Although there were some big movements in some shares this week, the outcome was pretty flat. The portfolio ended up by £349 reducing the deficit to £6,140 and increasing total value to £94,282.

The biggest loser was TEK:Tekcapital which has had a great few weeks, but this week there was a sell-off. The price dropped 11% in my trading account which had a sad week.

The other three big losers were all double digit climbers last week.

TLOU:Tlou Energy dropped 10% just as it looked like there was hope of a recovery. I suspect this was traders taking a profit.

JLP:Jubilee Metals fell 8% despite loads of good news and a healthy Q1 trading statement. Probably profit taking after the big rise last week.

IQE:IQE dropped 6% and still seems to be in the clutches of the shorters despite the big rise last week.

Only one share rose by more then 5% this week to earn Share of the Week and it was SBTX:SkinBioTherapeutics. It soared by 17% and is now only 4% down on my purchase price. Fingers crossed this rise will continue.

Hasn't done much to reduce the deficit.

The trend line deepens its dive. All rather worrying.

The ISA and share accounts look like this

	Weekly Change
Cash	£23.22		+£0
Portfolio cost	£57,274.78		+£0
Portfolio sell value (bid price - commission)	£52,376.68	(-8.6%)	+£60.17
Potential profits	£5,037.49		+£535.28
Yr 4 Dividends	£60.50		+£0
Yr 4 Profit from sales	£1,077.60		+£0
Yr 4 Average monthly cash profit	£119.64	(2.5%)	-£3.07
Total Dividends	£1,298.83		+£0
Total Profit from sales	£19,774.72		+£0
Average monthly cash profit	£461.93	(9.7%)	-£2.36
(Sold stocks profit + Dividends - Fees / Months)

Potential profits were up thanks to both OPTI:Optibiotix and CWR:Ceres Power climbing. However big losses elsewhere negated all that and the portfolio ended up by just £60. No dividends till next week.

As with the combined accounts, still too big a gap

Not far from the trend line so we may be able to drag it up towards flat at least until the first 5 or 6 weeks of the chart vanish, then I think we're doomed.

The SIPP looks like this after week 180

		Weekly Change
Cash	£59.50		+£0
Portfolio cost	£40,725.38		+£0
Portfolio sell value (bid price - commission)	£40,237.10	(-1.2%)	+£366.11
Potential profits	£3,872.48		+£535.91
Yr 4 Dividends	£0		+£0
Yr 4 Interest	£0.07		+£0
Yr 4 Profit from sales	£732.65		+£0
Yr 4 Average monthly cash profit	£118.67	(3.5%)	-£5.16
Total Dividends	£1,342.25		+£0
Total Interest	£0.09		+£0
Total Profit from sales	£11,277.57		+£0
Average monthly cash profit	£295.21	(8.7%)	-£1.65
(Sold stocks profit + Dividends - Fees / Months)

Similar story with OPTI:Optibiotix and CAML:Central Asia Metals both improving so potential profits up, but big losses elsewhere reduce the overall benefit to £366.

Still just about the wrong side of the red line

Still below the trend line and dragging it down.

The trading account looks like this after week 146

			Weekly Change
Cash	£18.80		+£0
Portfolio cost	£2,321.29		+£0
Portfolio sell value (bid price - commission)	£1,567.53	(-32.5%)	-£76.94
Potential profits	£0		+£0
Year 3 Dividends	£17.33		+£0
Year 3 Profit	£177.06		+£0
Yr 3 Average monthly cash profit	£20.06	(10.4%)	-£0.49
Dividends	£18.48		+£0
Profit from sales	-£64.29		+£0
Average monthly cash profit	-£1.36	(-0.7%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

All last week's gains wiped out and still no prospect of being able to sell anything.

So much for the recovery...

Stayed on the right side of the trend line so slowly pulling it flat.

That's it for this week. Still no opportunity to sell TND:Tandem Group and one of my potential targets SKIN:Integumen climbed 16% today so I may have missed the boat on that one. At the moment I'm leaning back towards increasing my holding in CEY:Centamin as everything else is up on price. The other option is more VRS:Versarien if it dips below 100p again. That's if I ever manage to get rid of TND:Tandem Group else I'll have no cash to buy anything.